Aster DM Healthcare Ltd

Aster DM Healthcare Ltd

₹ 427 -1.60%
21 Nov 4:00 p.m.
About

Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]

Key Points

Business Segments Q1 FY25
1) Hospitals and Clinics (94%): The company has a network of 19 hospitals (vs 14 hospitals in FY22) and 13 clinics. These hospitals are located in the Maharastra (1), Karnataka (4), Kerala (6), Andhra (6) & Telangana (1). [1]

This business has registered a 23% YoY revenue growth and EBITDA grew by 28% in FY24, on the backdrop of an increased bed capacity of 550 beds, and cost optimization measures. Material cost has declined from 25% in FY22 to 22% in FY24. [2] [3]

  • Market Cap 21,285 Cr.
  • Current Price 427
  • High / Low 558 / 311
  • Stock P/E 77.3
  • Book Value 68.8
  • Dividend Yield 0.47 %
  • ROCE 4.48 %
  • ROE 3.13 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Debtor days have improved from 127 to 23.0 days.

Cons

  • Stock is trading at 6.21 times its book value
  • The company has delivered a poor sales growth of -14.2% over past five years.
  • Company has a low return on equity of 9.44% over last 3 years.
  • Company might be capitalizing the interest cost
  • Promoters have pledged 98.9% of their holding.
  • Earnings include an other income of Rs.5,268 Cr.
  • Working capital days have increased from 155 days to 297 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
2,504 2,650 2,728 2,662 2,816 3,192 807 841 929 955 974 1,002 1,086
2,162 2,252 2,267 2,370 2,498 2,743 687 722 787 805 817 841 869
Operating Profit 343 397 460 292 319 449 120 119 142 149 156 161 217
OPM % 14% 15% 17% 11% 11% 14% 15% 14% 15% 16% 16% 16% 20%
10 12 22 37 18 10 149 -17 -64 153 -40 5,120 35
Interest 61 67 62 69 77 87 25 25 30 25 30 29 31
Depreciation 156 161 170 175 189 198 54 51 54 57 58 60 62
Profit before tax 135 181 250 85 71 173 190 26 -7 220 28 5,191 159
Tax % 6% 7% 2% 6% 23% 8% 4% 24% 120% 5% 108% 1% 33%
128 168 246 80 54 159 183 20 -15 209 -2 5,152 106
EPS in Rs 2.14 2.97 4.53 1.37 0.93 2.79 3.42 0.10 -0.62 3.59 -0.48 103.00 1.94
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1,922 2,871 3,876 5,250 5,931 6,721 7,963 8,652 8,608 10,253 2,994 3,699 4,017
1,660 2,421 3,370 4,805 5,582 6,089 6,886 7,187 7,506 8,720 2,547 3,124 3,333
Operating Profit 261 451 506 445 349 632 1,077 1,465 1,103 1,533 447 575 684
OPM % 14% 16% 13% 8% 6% 9% 14% 17% 13% 15% 15% 16% 17%
11 19 23 25 453 177 -155 -158 53 51 353 32 5,268
Interest 45 48 79 189 371 204 205 391 334 307 96 119 116
Depreciation 76 111 144 243 322 298 306 586 618 641 192 220 238
Profit before tax 151 310 306 38 108 308 410 330 205 637 511 268 5,599
Tax % 4% 9% 11% 78% 10% 8% 10% 5% 13% 6% 7% 21%
149 284 272 8 98 282 367 315 178 601 475 212 5,465
EPS in Rs 7.26 4.69 7.00 0.20 2.52 5.32 6.59 5.54 2.96 10.53 8.51 2.59 108.05
Dividend Payout % 0% 35% 0% 0% 0% 0% 0% 0% 0% 0% 0% 77%
Compounded Sales Growth
10 Years: 3%
5 Years: -14%
3 Years: -25%
TTM: -30%
Compounded Profit Growth
10 Years: -3%
5 Years: -23%
3 Years: -4%
TTM: 10%
Stock Price CAGR
10 Years: %
5 Years: 24%
3 Years: 31%
1 Year: 27%
Return on Equity
10 Years: 9%
5 Years: 9%
3 Years: 9%
Last Year: 3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 125 375 389 403 403 505 505 497 497 500 500 500 500
Reserves 654 536 1,096 17 1,472 2,327 2,709 2,775 2,875 3,080 3,574 3,686 2,936
505 886 1,091 3,321 2,758 2,352 2,788 5,605 4,804 5,282 6,075 1,758 1,940
856 1,097 1,834 2,003 2,171 2,296 2,926 3,528 3,444 3,661 4,687 12,039 1,312
Total Liabilities 2,140 2,894 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,836 17,983 6,688
872 1,087 2,237 2,507 3,520 3,738 4,289 7,124 6,749 7,009 9,052 3,175 3,867
CWIP 185 357 197 358 290 402 550 736 934 998 279 170 231
Investments 6 7 3 39 32 38 22 34 63 45 80 17 24
1,077 1,442 1,972 2,839 2,962 3,302 4,067 4,511 3,874 4,470 5,425 14,620 2,567
Total Assets 2,140 2,894 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,836 17,983 6,688

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
236 203 361 537 601 1,223 1,569 1,314 1,834 158
-439 -775 -1,136 -522 -702 -658 -333 -563 -951 -878
203 578 654 46 134 -675 -1,116 -686 -817 1,053
Net Cash Flow -1 5 -122 61 33 -110 120 65 66 332

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 95 86 83 93 79 84 93 100 86 72 285 23
Inventory Days 84 71 93 92 102 111 110 138 122 129 612 44
Days Payable 213 176 178 187 151 150 153 303 290 267 1,400 183
Cash Conversion Cycle -34 -18 -2 -1 30 45 50 -65 -83 -66 -503 -116
Working Capital Days 82 61 69 68 57 59 57 40 38 40 129 297
ROCE % 18% 14% 6% 1% 7% 13% 12% 6% 10% 3% 4%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
37.88% 37.88% 37.88% 37.88% 37.88% 41.88% 41.88% 41.88% 41.88% 41.88% 41.88% 41.88%
10.95% 11.03% 11.44% 11.77% 42.49% 38.63% 38.82% 40.22% 41.00% 33.48% 27.08% 23.86%
8.45% 8.64% 9.66% 8.99% 8.93% 8.93% 8.62% 7.64% 7.15% 13.70% 16.35% 20.91%
42.24% 41.99% 40.57% 40.91% 10.25% 10.12% 10.26% 9.85% 9.61% 10.59% 14.38% 13.05%
0.47% 0.46% 0.45% 0.45% 0.44% 0.43% 0.42% 0.41% 0.37% 0.35% 0.32% 0.30%
No. of Shareholders 80,74680,42778,37480,91384,57382,12971,37967,67367,33180,9312,06,6601,74,171

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls